Jan. 26, 2021—Molecule 147 neutralizes 95 percent of Dengue and Zika viruses, a promising direction for host-directed treatments and combination therapy.
Sep. 4, 2019—Researchers at Vanderbilt University Medical Center are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago.
Jan. 11, 2018—The U.S. Defense Advanced Research Projects Agency (DARPA) has signed a five-year cooperative agreement worth up to $28 million with Vanderbilt University Medical Center (VUMC) to develop methods for preventing the global spread of viruses like chikungunya and Zika.
Nov. 7, 2016—Researchers at Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have isolated a human monoclonal antibody that in a mouse model “markedly reduced” infection by the Zika virus.
Jun. 28, 2016—Summer is here, and the United States is bracing for the mosquito-transmitted Zika virus. A Vanderbilt researcher is working on one way to stop the spread of the disease – by revving up the mosquito’s taste buds.
May. 24, 2016—With summer time approaching and the topic of mosquitoes abuzz, Vanderbilt University Medical Center Maternal Fetal Medicine specialist Sarah Osmundson, M.D., has a few recommendations for women who are pregnant or want to become pregnant.
Feb. 4, 2016—The Centers for Disease Control and Prevention (CDC) has issued a travel advisory for visitors to parts of South America, Central America, the Caribbean, Mexico, Samoa and Cape Verde where Zika virus transmission is ongoing.